PBH - CIK 0001295947
The table below shows Prestige Consumer Healthcare Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $257.63M | $251.51M | $248.93M | $229.72M | $259.92M | $235.61M |
| Capital expenditure | $11.18M | $8.22M | $9.55M | $7.78M | $9.64M | $22.24M |
| Investing cash flow | -$136.84M | -$17.45M | -$20.11M | -$11.58M | -$256.51M | -$22.24M |
| Dividends paid | - | - | - | - | - |
Prestige Consumer Healthcare Inc. reported operating cash flow of $257.63M for fiscal year 2026. That is up 2.4% from $251.51M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $148.67M (FY 2017) to $257.63M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $156.28M | $51.51M | $25.00M | $50.00M | $0.00 | $11.87M |
| Financing cash flow | -$156.06M | -$182.07M | -$241.01M | -$185.85M | -$7.57M | -$279.42M |